FDA Inspection 1142920 — Biomat USA, Inc
The FDA completed an inspection of Biomat USA, Inc on April 26, 2021 in Maywood, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 26, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Maywood, IL (United States)